Position in NTRA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$32,845
+$24,927 QoQ
Shares Held
121
+116.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#714
of 844 holders
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Continuum Advisory, LLC holds $2,215,499 across 16 Diagnostics & Research names. NTRA ranks #6 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,562 | $1,284,484 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
2,596 | $501,599 | |
| 3 | DGX |
Quest Diagnostics Inc
|
611 | $129,501 | |
| 4 | DHR |
Danaher Corp /De/
|
481 | $91,620 | |
| 5 | LH |
Labcorp Holdings Inc.
|
297 | $83,160 | |
| 6 | NTRA |
Natera, Inc.
This page
|
121 | $32,845 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
134 | $30,389 | |
| 8 | ILMN |
Illumina, Inc.
|
105 | $18,462 |
All Filings in NTRA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,845 | 121 | Shares | Sole | 2026-08-06 | |
| 2025-03-31 | $7,918 | 56 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $27,860 | 176 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $25,897 | 204 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $26,964 | 249 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $30,364 | 332 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||